We tested NKCE killing specificity on HeLa cells, a breast cancer cell line expressing both EGFR and B7-H6, or SK-BR-3 cells, a breast cancer cell line expressing both HER2 and B7-H6. This evidence concerns the gene ERBB2 and breast carcinoma.